| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |


*Kidney Disease Section, Metabolic Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland; and
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Correspondence to Dr. Jeffrey Kopp, 10 Center Drive, MSC 1268, Bethesda, MD 20892. Phone: 301-594-3403; Fax: 301-402-0014;
ABSTRACT. The podocyte plays a key role in glomerular function and glomerular disease. To facilitate studies of podocyte function, we have developed a transgenic mouse model with inducible expression in the podocyte. The tetracycline-inducible transgenic system facilitates gene expression with restricted cellular distribution and tight temporal control. Recently, Bujard and colleagues have developed a functionally improved reverse tetracyclinecontrolled transcriptional activator (rtTA) with substantially lower background in the off state (the absence of tetracycline) and greater inducibility in the on state (the presence of tetracycline). We used the human podocin (NPHS2) gene promoter to control expression of the rtTA cassette and bred these mice with a reporter mouse line that contains the cytomegalovirus minimal promoter and tetO promoter elements together with LacZ, encoding
-galactosidase. Dual transgenic mice, bearing both podocin-rtTA and tetO-LacZ transgenes, had no detectable expression in kidney or other organs in the absence of tetracycline. Administration of tetracycline in the drinking water was associated with podocyte expression of
-galactosidase, in a fashion that was time dependent (maximal at 1 wk) and dose-dependent (maximal at 2 mg/ml). Podocyte expression was confirmed in two ways: histochemical staining for
-galactosidase and double-immunostaining using the podocyte marker WT-1 and
-galactosidase. This transgenic system should aid future investigations of podocyte function. E-mail: jbkopp@nih.gov
This article has been cited by other articles:
![]() |
L. Wang, P. J. Flannery, P. B. Rosenberg, T. A. Fields, and R. F. Spurney Gq-Dependent Signaling Upregulates COX2 in Glomerular Podocytes J. Am. Soc. Nephrol., November 1, 2008; 19(11): 2108 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Ku, K. E. White, A. Dei Cas, A. Hayward, Z. Webster, R. Bilous, S. Marshall, G. Viberti, and L. Gnudi Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice Diabetes, October 1, 2008; 57(10): 2824 - 2833. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Davis, A. Dei Cas, D. A. Long, K. E. White, A. Hayward, C.-H. Ku, A. S. Woolf, R. Bilous, G. Viberti, and L. Gnudi Podocyte-Specific Expression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2320 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hiramatsu, K. Hiromura, T. Shigehara, T. Kuroiwa, H. Ideura, N. Sakurai, S. Takeuchi, M. Tomioka, H. Ikeuchi, Y. Kaneko, et al. Angiotensin II Type 1 Receptor Blockade Inhibits the Development and Progression of HIV-Associated Nephropathy in a Mouse Model J. Am. Soc. Nephrol., February 1, 2007; 18(2): 515 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Juhila, R. Roozendaal, M. Lassila, S. J. Verbeek, and H. Holthofer Podocyte Cell-Specific Expression of Doxycycline Inducible Cre Recombinase in Mice J. Am. Soc. Nephrol., March 1, 2006; 17(3): 648 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gawlik and S. E. Quaggin Deciphering the Renal Code: Advances in Conditional Gene Targeting Physiology, October 1, 2004; 19(5): 245 - 252. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673